PortfoliosLab logoPortfoliosLab logo
HELX vs. TYLD
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

HELX vs. TYLD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Franklin Genomic Advancements ETF (HELX) and Cambria Tactical Yield ETF (TYLD). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

HELX vs. TYLD - Yearly Performance Comparison


2026 (YTD)20252024
HELX
Franklin Genomic Advancements ETF
-8.96%26.34%-4.03%
TYLD
Cambria Tactical Yield ETF
0.80%4.05%5.15%

Returns By Period

In the year-to-date period, HELX achieves a -8.96% return, which is significantly lower than TYLD's 0.80% return.


HELX

1D
4.58%
1M
-4.31%
YTD
-8.96%
6M
7.21%
1Y
22.89%
3Y*
2.98%
5Y*
-5.38%
10Y*

TYLD

1D
0.06%
1M
0.34%
YTD
0.80%
6M
1.91%
1Y
4.13%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


HELX vs. TYLD - Expense Ratio Comparison

HELX has a 0.50% expense ratio, which is lower than TYLD's 0.59% expense ratio.


Return for Risk

HELX vs. TYLD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HELX
HELX Risk / Return Rank: 4949
Overall Rank
HELX Sharpe Ratio Rank: 5454
Sharpe Ratio Rank
HELX Sortino Ratio Rank: 5656
Sortino Ratio Rank
HELX Omega Ratio Rank: 4848
Omega Ratio Rank
HELX Calmar Ratio Rank: 4646
Calmar Ratio Rank
HELX Martin Ratio Rank: 4141
Martin Ratio Rank

TYLD
TYLD Risk / Return Rank: 9898
Overall Rank
TYLD Sharpe Ratio Rank: 9898
Sharpe Ratio Rank
TYLD Sortino Ratio Rank: 9898
Sortino Ratio Rank
TYLD Omega Ratio Rank: 9999
Omega Ratio Rank
TYLD Calmar Ratio Rank: 9898
Calmar Ratio Rank
TYLD Martin Ratio Rank: 9898
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HELX vs. TYLD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Franklin Genomic Advancements ETF (HELX) and Cambria Tactical Yield ETF (TYLD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


HELXTYLDDifference

Sharpe ratio

Return per unit of total volatility

0.95

3.11

-2.16

Sortino ratio

Return per unit of downside risk

1.45

4.72

-3.27

Omega ratio

Gain probability vs. loss probability

1.18

2.00

-0.82

Calmar ratio

Return relative to maximum drawdown

1.18

8.01

-6.84

Martin ratio

Return relative to average drawdown

3.85

34.71

-30.86

HELX vs. TYLD - Sharpe Ratio Comparison

The current HELX Sharpe Ratio is 0.95, which is lower than the TYLD Sharpe Ratio of 3.11. The chart below compares the historical Sharpe Ratios of HELX and TYLD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


HELXTYLDDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.95

3.11

-2.16

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.22

Sharpe Ratio (All Time)

Calculated using the full available price history

0.20

2.48

-2.27

Correlation

The correlation between HELX and TYLD is 0.02, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

HELX vs. TYLD - Dividend Comparison

HELX's dividend yield for the trailing twelve months is around 0.43%, less than TYLD's 4.72% yield.


TTM202520242023202220212020
HELX
Franklin Genomic Advancements ETF
0.43%0.39%0.00%0.00%0.00%0.24%0.12%
TYLD
Cambria Tactical Yield ETF
4.72%4.38%4.24%0.00%0.00%0.00%0.00%

Drawdowns

HELX vs. TYLD - Drawdown Comparison

The maximum HELX drawdown since its inception was -58.75%, which is greater than TYLD's maximum drawdown of -1.06%. Use the drawdown chart below to compare losses from any high point for HELX and TYLD.


Loading graphics...

Drawdown Indicators


HELXTYLDDifference

Max Drawdown

Largest peak-to-trough decline

-58.75%

-1.06%

-57.69%

Max Drawdown (1Y)

Largest decline over 1 year

-18.01%

-0.52%

-17.49%

Max Drawdown (5Y)

Largest decline over 5 years

-58.75%

Current Drawdown

Current decline from peak

-42.87%

0.00%

-42.87%

Average Drawdown

Average peak-to-trough decline

-34.11%

-0.11%

-34.00%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.50%

0.12%

+5.38%

Volatility

HELX vs. TYLD - Volatility Comparison

Franklin Genomic Advancements ETF (HELX) has a higher volatility of 8.77% compared to Cambria Tactical Yield ETF (TYLD) at 0.24%. This indicates that HELX's price experiences larger fluctuations and is considered to be riskier than TYLD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


HELXTYLDDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.77%

0.24%

+8.53%

Volatility (6M)

Calculated over the trailing 6-month period

15.44%

0.50%

+14.94%

Volatility (1Y)

Calculated over the trailing 1-year period

24.24%

1.34%

+22.90%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

24.26%

1.82%

+22.44%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

27.47%

1.82%

+25.65%